Page last updated: 2024-09-04

perifosine and Leiomyosarcoma

perifosine has been researched along with Leiomyosarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alberti, D; Arzoomanian, R; Binger, K; Kolesar, J; Marnocha, R; Tutsch, K; Van Ummersen, L; Volkman, J; Wilding, G	1

Trials

1 trial(s) available for perifosine and Leiomyosarcoma

Article	Year
A phase I trial of perifosine (NSC 639966) on a loading dose/maintenance dose schedule in patients with advanced cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Nov-15, Volume: 10, Issue:22 Topics: Adult; Aged; Antineoplastic Agents; Dexamethasone; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leiomyosarcoma; Loperamide; Male; Maximum Tolerated Dose; Middle Aged; Models, Chemical; Neoplasms; Phosphorylcholine; Serotonin 5-HT3 Receptor Antagonists; Signal Transduction; Time Factors; Treatment Outcome	2004

Article

Year

A phase I trial of perifosine (NSC 639966) on a loading dose/maintenance dose schedule in patients with advanced cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Nov-15, Volume: 10, Issue:22

Topics: Adult; Aged; Antineoplastic Agents; Dexamethasone; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leiomyosarcoma; Loperamide; Male; Maximum Tolerated Dose; Middle Aged; Models, Chemical; Neoplasms; Phosphorylcholine; Serotonin 5-HT3 Receptor Antagonists; Signal Transduction; Time Factors; Treatment Outcome

2004